Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico

Seroprevalence surveys provide estimates of the extent of SARS-CoV-2 infections in the population, regardless of disease severity and test availability. In Mexico in 2020, COVID-19 cases reached a maximum in July and December. We aimed to estimate the national and regional seroprevalence of SARS-CoV...

Descripción completa

Detalles Bibliográficos
Autores principales: Basto-Abreu, Ana, Carnalla, Martha, Torres-Ibarra, Leticia, Romero-Martínez, Martín, Martínez-Barnetche, Jesús, López-Martínez, Irma, Aparicio-Antonio, Rodrigo, Shamah-Levy, Teresa, Alpuche-Aranda, Celia, Rivera, Juan A., Barrientos-Gutierrez, Tonatiuh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807586/
https://www.ncbi.nlm.nih.gov/pubmed/35105873
http://dx.doi.org/10.1038/s41467-022-28232-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807586/
https://www.ncbi.nlm.nih.gov/pubmed/35105873
http://dx.doi.org/10.1038/s41467-022-28232-9

Ejemplares similares